The highest overall response rate (ORR) was observed in patients treated with the lowest dose of axatilimab at 0.3 mg/kg every 2 weeks, with an ORR of 74% (95% CI 63-83) within the first 6 months, ...
Please provide your email address to receive an email when new articles are posted on . Four of six patients who used sirolimus had positive responses and discontinued systemic corticosteroids. Three ...
Primary end point was met, with overall response for 74, 67, and 50% receiving axatilimab 0.3-, 1-, and 3mg per kilogram of body weigh HealthDay News — For patients with recurrent or refractory ...
For over 60 years, the search for an effective pharmacologic treatment for refractory or unexplained chronic cough has been ...
Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor–Resistant Chemotherapy-Naïve Advanced Non–Small Cell Lung Cancer: A Meta-Analysis Based on Eight Randomized ...
9don MSN
Expert guidance urges caution before surgery for patients with treatment-resistant constipation
A new update from the American Gastroenterological Association (AGA) is calling for greater caution before surgery is ...
Please provide your email address to receive an email when new articles are posted on . These results, published in JAMA in conjunction with a presentation at the European Respiratory Society ...
From December 4 to 6, 2025, the 5th International Cough Conference (ICC) was successfully held in Guangzhou, China. This ...
A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback